MoonLake Immunotherapeutics (MLTX) EBT (2021 - 2026)
MoonLake Immunotherapeutics' (MLTX) quarterly EBT came in at -$69.1 million in Q1 2026, down 70.98% year-on-year from -$238.0 million in Q1 2025, and down 10.06% quarter-over-quarter from -$62.8 million in Q4 2025.
MoonLake Immunotherapeutics (MLTX) EBT (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' EBT history runs 6 years deep, the most recent figure standing at -$69.1 million for Q1 2026.
- On a quarterly basis, EBT fell 70.98% year-over-year to -$69.1 million in Q1 2026; TTM through Mar 2026 was -$258.4 million, a 75.22% decrease from a year earlier, with the FY2025 full-year figure at -$229.7 million, down 89.9% from the prior year.
- EBT declined to -$69.1 million in Q1 2026 per MLTX's latest filing, from -$62.8 million in the prior quarter.
- Across five years, EBT topped out at -$7.8 million in Q4 2023 and bottomed at -$70.6 million in Q3 2025.
- The 5-year median for EBT is -$17.4 million (2022), against an average of -$31.1 million.
- Biggest YoY gain for EBT was 69.32% in 2022; the steepest drop was 20705.61% in 2022.
- Year by year, EBT stood at -$16.5 million in 2022, then soared by 52.34% to -$7.8 million in 2023, then sank by 491.0% to -$46.4 million in 2024, then plunged by 35.41% to -$62.8 million in 2025, then retreated by 10.06% to -$69.1 million in 2026.
- Per Business Quant, the three latest MLTX EBT figures stand at -$69.1 million (Q1 2026), -$62.8 million (Q4 2025), and -$70.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | MoonLake Immunotherapeutics | 1.38 Bn | 1.02 Bn | - | -69.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.09 Mn |
| Dec 31, 2025 | -62.77 Mn |
| Sep 30, 2025 | -70.58 Mn |
| Jun 30, 2025 | -55.96 Mn |
| Mar 31, 2025 | -40.41 Mn |
| Dec 31, 2024 | -46.35 Mn |
| Sep 30, 2024 | -36.02 Mn |
| Jun 30, 2024 | -24.68 Mn |
| Mar 31, 2024 | -13.91 Mn |
| Dec 31, 2023 | -7.84 Mn |
| Sep 30, 2023 | -11.59 Mn |
| Jun 30, 2023 | -12.34 Mn |
| Mar 31, 2023 | -12.21 Mn |
| Dec 31, 2022 | -16.46 Mn |
| Sep 30, 2022 | -14.73 Mn |
| Jun 30, 2022 | -17.41 Mn |
| Mar 31, 2022 | -15.87 Mn |
| Dec 31, 2021 | -53.64 Mn |
| Sep 30, 2021 | -6.29 Mn |
| Jun 30, 2021 | -32.69 Mn |